InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: Easymoneyman00 post# 37250

Thursday, 10/05/2017 11:40:42 AM

Thursday, October 05, 2017 11:40:42 AM

Post# of 108191
Easy, I did not mean to imply the HER2 trial in canines did not do well, I was just quoting from a post. When I saw that it more than doubled OS, I was floored. Those are great results. My thought, like some others here, is Big Tony is pushing those constructs that are far along enough (and partially paid for) to get us to approval in a quicker fashion. Some have stated the longer it takes us to get to the promised land the quicker competition will overtake us. Advances are coming at an incredible rate now as opposed to just a short time ago and there will always be newer, better treatments coming up behind us (and everyone else. The beauty of Advaxis, I think, is it can be and will be used in combination with just about anything that is current or new. When the HER2 results from the human trials are released and assuming they are good, that could up the interest and value that licensing could bring.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News